The Good News and Bad News About Where Precision Medicine Stands in 2020
Effective communication with providers and patients can bridge the gap that exists between precision medicine’s benefits and wider patient access...
Clinical Outcomes
To Demonstrate Precision Medicine Utility, Focus on Pharmacogenetics Studies and Data
Focus on pharmacogenetics studies and data that demonstrate costs savings and improved outcomes...
Precision Medicine Programs Can Attain ROI Sooner Than Some Naysayers Maintain
Focusing on the right factors can accelerate a precision medicine program’s ROI...
Hospitals Hit with Readmission Penalties; Some of Those Not Hit Used Precision Medicine in Strategy
As CMS announces readmission penalties for nearly 2,600 hospitals, some hospitals and health systems are finding precision medicine and big data efforts to be a new strategy for reducing 30-day readmissions...
Hospital CEOs: McKinsey says "Hospitals Are Dead. Long Live the Hospital"
Trends affecting hospitals and health systems worldwide are forcing them to alter how they are structured and how they deliver care. Here’s how precision medicine factors in...
Do Multigene Panels Offer Cancer Patients, Payers More Value?
Daryl Pritchard, PhD, discusses the untapped potential of multi-gene panel sequencing and targeted therapies for patients with advanced cancer....
Why the Cleveland Clinic Uses Telegenetics, Chatbots to Address Genetic Cancer Risk
Charis Eng, MD, PhD, explains how the Cleveland Clinic is overcoming workforce challenges in clinical cancer genetics...
Considering Risks and Privacy in Genetic Medicine: Q&A with Dr. Paul S. Appelbaum
Paul S. Appelbaum, MD, provides deeper insights into risks, privacy, and safeguarding patients’ genetic information...
How Healthcare Organizations Can Drive Diversity in Genetic Research
Joshua C. Denny, MD, explains the importance of diverse genetic data in fueling precision-medicine breakthroughs...
Illumina Seeks to Reduce Burdens of Adopting Precision Medicine
Phil Febbo, MD, CMO of sequencing company Illumina, to discuss what company is doing to make it easier for health systems to adopt next-generation sequencing...